Ifp Advisors, Inc Marker Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$0.24 - $4.58 $284 - $5,427	1,185 Added 51.19%	3,500 $30,000
Q3 2022 Nov 08, 2022	BUY	$0.3 - $3.73 $394 - $4,904	1,315 Added 131.5%	2,315 $20,000
Q2 2022 Sep 06, 2022	BUY	$0.26 - $0.46 $260 - $460	1,000 New	1,000 $9,000
Q2 2022 Aug 12, 2022	SELL	$0.26 - $0.46 $260 - $460	-1,000 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$0.37 - $1.0 $370 - $1,000	1,000 New	1,000 $0

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $163M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.